Verrica Pharmaceuticals Inc. (VRCA) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.00K; Additional Paid in Capital, Common StockUSD $352.05M; Treasury Stock, ValueUSD $0.00.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.00K; Additional Paid in Capital, Common StockUSD $350.65M; Treasury Stock, ValueUSD $0.00.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.00K; Additional Paid in Capital, Common StockUSD $349.65M; Treasury Stock, ValueUSD $0.00.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $299.80M; Treasury Stock, ValueUSD $0.00.
Verrica Pharmaceuticals Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Value USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $2.00K | $352.05M | $0.00 | $-347.75M | $4.31M | 10.51K | (m) | 3 month · $1.21M | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $2.00K | $350.65M | $0.00 | $-334.60M | $16.05M | 10.51K | 3 month · $9.00K | 3 month · $897.00K | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $2.00K | $349.65M | $0.00 | $-324.91M | $24.74M | 10.51K | (m) | 12 month · $3.32M | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $1.00K | $299.80M | $0.00 | $-316.84M | $-17.04M | 10.51K | (m) | 3 month · $718.00K | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $1.00K | $299.08M | $0.00 | $-316.56M | $-17.48M | 10.51K | (m) | 3 month · $888.00K | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $9.00K | $298.18M | $0.00 | $-316.77M | $-18.58M | 105.14K | (m) | 3 month · $1.03M | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $1.00K | $297.17M | $0.00 | $-307.03M | $-9.86M | 10.51K | (m) | 12 month · $7.16M | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $5.00K | $256.77M | $0.00 | $-290.82M | $-34.05M | 105.14K | (m) | 3 month · $2.11M | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $4.00K | $254.66M | $0.00 | $-267.96M | $-13.30M | 105.14K | (m) | 3 month · $2.23M | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $4.00K | $252.29M | $0.00 | $-250.78M | $1.51M | 105.14K | (m) | 3 month · $2.07M | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $4.00K | $250.21M | $0.00 | $-230.45M | $19.76M | 105.14K | (m) | 12 month · $14.38M | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $4.00K | $248.13M | $0.00 | $-205.83M | $42.30M | 105.14K | (m) | 3 month · $9.66M | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $4.00K | $236.43M | $0.00 | $-181.03M | $55.40M | 105.14K | (m) | 3 month · $1.54M | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $4.00K | $234.88M | $0.00 | $-170.04M | $64.85M | (m) | (m) | 3 month · $1.09M | (m) | (m) | 105.14K |
| 2022-12-31 | $0.00 | $4.00K | $203.48M | $0.00 | $-163.45M | $40.03M | 105.14K | (m) | 12 month · $4.99M | (m) | $0.00 | 105.14K |
| 2022-09-30 | $0.00 | $4.00K | $202.31M | $0.00 | $-157.52M | $44.77M | (m) | (m) | 3 month · $1.41M | (m) | $-29.00K | 105.14K |
| 2022-06-30 | $0.00 | $3.00K | $174.00M | $0.00 | $-157.60M | $16.33M | (m) | (m) | 3 month · $1.08M | (m) | $-64.00K | 105.14K |
| 2022-03-31 | $0.00 | $3.00K | $172.91M | $0.00 | $-147.44M | $25.42M | (m) | (m) | 3 month · $1.32M | (m) | $-62.00K | 105.14K |
| 2021-12-31 | $0.00 | $3.00K | $171.60M | $0.00 | $-138.97M | $32.60M | (m) | (m) | 12 month · $6.05M | (m) | $-29.00K | 105.14K |
| 2021-09-30 | (m) | $3.00K | $170.28M | $0.00 | $-129.43M | $40.85M | (m) | (m) | 3 month · $1.48M | (m) | $-2.00K | 105.14K |
| 2021-06-30 | (m) | $3.00K | $168.75M | (m) | $-116.60M | $52.16M | (m) | (m) | 3 month · $1.85M | (m) | $-1.00K | (m) |
| 2021-03-31 | (m) | $3.00K | $166.63M | $0.00 | $-104.82M | $61.81M | (m) | (m) | 3 month · $1.40M | (m) | $3.00K | 105.14K |
| 2020-12-31 | (m) | $3.00K | $136.87M | $0.00 | $-103.89M | $32.99M | (m) | (m) | 12 month · $9.82M | (m) | $1.00K | 105.14K |
| 2020-09-30 | (m) | $3.00K | $130.53M | $0.00 | $-90.91M | $39.18M | (m) | (m) | 3 month · $1.23M | (m) | $6.00K | 105.14K |
| 2020-06-30 | (m) | $3.00K | $128.85M | $0.00 | $-80.42M | $48.46M | (m) | (m) | 3 month · $1.25M | (m) | $32.00K | 105.14K |
| 2020-03-31 | (m) | $3.00K | $127.60M | $0.00 | $-71.01M | $56.61M | (m) | (m) | 3 month · $998.00K | (m) | $20.00K | 105.14K |
| 2019-12-31 | (m) | $3.00K | $126.59M | $0.00 | $-61.19M | $65.02M | (m) | (m) | 12 month · $3.33M | (m) | $20.00K | 105.14K |
| 2019-09-30 | (m) | $3.00K | $125.18M | $0.00 | $-53.55M | $71.65M | (m) | (m) | 3 month · $905.00K | (m) | $27.00K | 105.14K |
| 2019-06-30 | (m) | $3.00K | $124.27M | $0.00 | $-47.47M | $76.84M | (m) | (m) | 3 month · $846.00K | (m) | $38.00K | 105.14K |
| 2019-03-31 | (m) | $3.00K | $123.21M | $0.00 | $-40.46M | $82.76M | (m) | (m) | 3 month · $780.00K | (m) | $11.00K | 105.14K |
| 2018-12-31 | (m) | $3.00K | $122.53M | $0.00 | $-33.08M | $89.43M | (m) | (m) | 12 month · $2.25M | (m) | $-17.00K | 105.14K |
| 2018-09-30 | (m) | $3.00K | $123.36M | $0.00 | $-27.01M | $96.35M | (m) | 3 month · $7.00K | 3 month · $683.00K 9 month · $3.10M | (m) | $-7.00K | 105.14K |
| 2018-06-30 | (m) | $3.00K | (m) | $0.00 | $-20.27M | $101.59M | (m) | (m) | 3 month · $779.00K 6 month · $1.58M | $121.86M | (m) | 105.14K |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | $-8.75M | (m) | (m) | 3 month · $135.00K | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | $5.39M | $0.00 | $-12.44M | $-7.04M | (m) | (m) | 12 month · $82.00K | $5.39M | (m) | 105.14K |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | $-2.66M | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |